Opportunity Information: Apply for RFA AI 24 003
The Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical Trial Not Allowed) funding opportunity (RFA-AI-24-003) is a National Institutes of Health (NIH) cooperative agreement designed to strengthen the nations ability to respond to radiation public health emergencies. It focuses on advancing radiation biodosimetry, meaning the measurement of radiation exposure and its biological impact, to support medical triage and decision-making when large numbers of people may be exposed. The program supports work across the development pipeline, from early discovery efforts that identify promising biomarkers of radiation injury to more advanced development of practical assays or devices that could eventually move toward regulatory review and approval.
The core scientific aim is to develop new or improved ways to identify biomarkers of injury and translate them into usable tests or devices for emergency response. Projects can target approaches that help estimate absorbed dose, which is critical for sorting people by likely exposure level, or predict meaningful health outcomes, including both acute radiation injury and delayed effects that may emerge over time. The emphasis is on tools that can be used for triage, so practicality, speed, scalability, and usefulness in real-world emergency conditions are central considerations. The opportunity is structured to encourage development that is sufficiently rigorous and performance-driven to position successful technologies for future regulatory pathways, even though this announcement does not itself fund clinical trials.
The award mechanism is a U01 cooperative agreement, which typically means NIH will have substantial scientific and programmatic involvement during the project period compared with a standard research grant. In practice, applicants should expect a more collaborative relationship with the funding institute, with shared responsibilities around milestones, coordination, and translation-oriented progress expectations. The funding instrument is listed under the health activity category and is associated with CFDA 93.855.
Eligibility is broad across the U.S. research and response ecosystem. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status; for-profit organizations other than small businesses; small businesses; and other types of domestic organizations. The NOFO also explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions.
Foreign participation is constrained in a way that is common for emergency preparedness-related programs. Non-domestic (non-U.S.) entities are not eligible to apply as the primary applicant, and non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed, which means a U.S. applicant may include certain scientifically justified foreign collaborations or elements under NIH rules, even though the primary applicant organization must be domestic.
Key administrative details in the provided source include an original closing date of May 31, 2024, and an award ceiling listed as $350,000. The opportunity was created on January 25, 2024. While the expected number of awards is not specified in the excerpt, the overall program intent is clear: to accelerate innovative biodosimetry science into usable assays and devices that can support rapid, reliable triage and health risk prediction after radiation exposure, ultimately helping the U.S. prepare for and respond to radiological or nuclear incidents with tools that are better positioned for future regulatory approval.Apply for RFA AI 24 003
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855.
- This funding opportunity was created on 2024-01-25.
- Applicants must submit their applications by 2024-05-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $350,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the funding opportunity called?
The opportunity is titled "Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical Trial Not Allowed)" and is identified as RFA-AI-24-003.
Which federal agency is offering this grant?
This is a National Institutes of Health (NIH) funding opportunity.
What is the main purpose of this program?
The program is designed to strengthen the nation's ability to respond to radiation public health emergencies by advancing radiation biodosimetry tools that support medical triage and decision-making when large numbers of people may be exposed.
What is radiation biodosimetry in the context of this opportunity?
Radiation biodosimetry refers to measuring radiation exposure and its biological impact. In this program, it is used to help estimate exposure and predict health impacts so responders can make informed triage decisions during emergencies.
What kinds of projects does this opportunity support?
The program supports work across the development pipeline, including early discovery efforts to identify promising biomarkers of radiation injury and more advanced development of practical assays or devices that could later move toward regulatory review and approval.
What is the core scientific aim of the program?
The central aim is to develop new or improved ways to identify biomarkers of radiation injury and translate them into usable tests or devices for emergency response.
What outcomes or endpoints can proposed technologies focus on?
Projects may target approaches that help estimate absorbed radiation dose and/or predict meaningful health outcomes, including acute radiation injury as well as delayed effects that may emerge over time.
Why does the opportunity emphasize triage use?
The tools are intended for real-world emergency response. Because triage may involve large numbers of potentially exposed people, practicality, speed, scalability, and usefulness in emergency conditions are central considerations.
Does this opportunity fund clinical trials?
No. The announcement is explicitly labeled "Clinical Trial Not Allowed."
What is the award mechanism?
The award mechanism is a U01 cooperative agreement.
What does it mean that this is a U01 cooperative agreement?
A U01 typically involves substantial NIH scientific and programmatic involvement during the project period compared with a standard research grant. Applicants should expect a more collaborative relationship with NIH, including shared responsibilities around milestones, coordination, and translation-oriented progress expectations.
Is the program intended to support technologies on a path toward regulation?
Yes. While the opportunity does not fund clinical trials, it emphasizes performance-driven development intended to position successful assays or devices for future regulatory pathways.
What is the CFDA number associated with this opportunity?
The opportunity is associated with CFDA 93.855.
Who is eligible to apply?
Eligibility is broad and includes many domestic U.S. organization types, including governmental entities, educational institutions, nonprofits, and for-profits, as well as small businesses and other domestic organizations.
Are state and local government entities eligible?
Yes. Eligible applicants include state, county, city or township governments, and special district governments.
Are schools and higher education institutions eligible?
Yes. Independent school districts, public and state-controlled institutions of higher education, and private institutions of higher education are eligible.
Are tribal governments and tribal organizations eligible?
Yes. Federally recognized Native American tribal governments are eligible, and tribal organizations other than federally recognized tribal governments are also listed as eligible.
Are nonprofits eligible, including those without 501(c)(3) status?
Yes. Nonprofit organizations with or without 501(c)(3) status are eligible.
Are for-profit organizations eligible?
Yes. For-profit organizations other than small businesses are eligible, and small businesses are also eligible.
Are faith-based or community-based organizations eligible?
Yes. The NOFO explicitly highlights faith-based or community-based organizations among eligible applicant types.
Are U.S. territories or possessions included in eligibility?
Yes. U.S. territories or possessions are explicitly highlighted as eligible.
Are minority-serving institutions specifically mentioned as eligible?
Yes. The NOFO explicitly highlights Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, and TCCUs.
Can a non-U.S. (foreign) organization apply as the primary applicant?
No. Non-domestic (non-U.S.) entities are not eligible to apply as the primary applicant.
Can a non-U.S. component of a U.S. organization apply?
No. Non-domestic components of U.S. organizations are also not eligible to apply.
Are any foreign collaborations allowed?
Yes. Foreign components (as defined in the NIH Grants Policy Statement) are allowed when included by an eligible U.S. applicant under NIH rules and when scientifically justified, even though the primary applicant must be domestic.
What is the original closing date listed for this opportunity?
The provided information lists an original closing date of May 31, 2024.
What is the award ceiling listed in the provided information?
The award ceiling is listed as $350,000.
When was this opportunity created?
The opportunity was created on January 25, 2024.
Is the expected number of awards stated in the provided information?
No. The excerpt does not specify the expected number of awards.
What kinds of deliverables are encouraged by this program?
The opportunity encourages translation of biodosimetry biomarkers into practical assays or devices suitable for emergency use, with an emphasis on rigorous, performance-driven development aligned with future regulatory positioning.
What types of emergencies is this program intended to address?
The program is aimed at radiation public health emergencies, including scenarios where a radiological or nuclear incident could expose large numbers of people.
Browse more opportunities from the same category: Health
Next opportunity: FY24 Bureau of Land Management Oregon/Washington (ORWA) Secure Rural Schools Title II
Previous opportunity: FY24 IIJA/IRA Bureau of Land Management MT/DAK Youth Conservation Corps
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AI 24 003
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AI 24 003) also looked into and applied for these:
| Funding Opportunity |
|---|
| USAID/Kenya and East Africa Global Health Security (GHS) Activity Apply for 72061524RFI00002 Funding Number: 72061524RFI00002 Agency: Kenya USAID-Nairobi Category: Health Funding Amount: Case Dependent |
| NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) Apply for PAR 24 099 Funding Number: PAR 24 099 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 24 100 Funding Number: PAR 24 100 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Localization in Health Apply for 620 24 0002 Funding Number: 620 24 0002 Agency: Nigeria USAID-Abuja Category: Health Funding Amount: Case Dependent |
| NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) Apply for PAR 24 124 Funding Number: PAR 24 124 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) Apply for PAR 24 116 Funding Number: PAR 24 116 Agency: National Institutes of Health Category: Health Funding Amount: $1,050,000 |
| NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) Apply for PAR 24 115 Funding Number: PAR 24 115 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 24 123 Funding Number: PAR 24 123 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| USAID Strengthening Local Health Security Apply for 72044024RFA00001 Funding Number: 72044024RFA00001 Agency: USAID-VIETNAM Category: Health Funding Amount: $21,500,000 |
| Mechanistic Investigations into ADRD Multiple Etiology Dementias (R01 - Clinical Trial Not Allowed) Apply for PAR 24 147 Funding Number: PAR 24 147 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01 - Clinical Trial Not Allowed) Apply for PAR 24 148 Funding Number: PAR 24 148 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Multi-Scale Models Bridging Levels of Analysis in Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R01 Clinical Trial Not Allowed) Apply for RFA AG 25 016 Funding Number: RFA AG 25 016 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| AHRQ Small Health Services Research Grant Program (R03) Apply for PA 24 155 Funding Number: PA 24 155 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $100,000 |
| AHRQ Health Services Research Projects (R01) Apply for PA 24 154 Funding Number: PA 24 154 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required) Apply for PAR 24 125 Funding Number: PAR 24 125 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Health Services Research Demonstration and Dissemination Grants (R18) Apply for PA 24 156 Funding Number: PA 24 156 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Required) Apply for PAR 24 140 Funding Number: PAR 24 140 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Not Allowed) Apply for PAR 24 143 Funding Number: PAR 24 143 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required) Apply for PAR 24 142 Funding Number: PAR 24 142 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD's Mentored Research Education Pathway for Otolaryngology Residents and Medical Students (R25 - Clinical Trial Not Allowed) Apply for PAR 24 127 Funding Number: PAR 24 127 Agency: National Institutes of Health Category: Health Funding Amount: $499,999 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AI 24 003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.